Colletti V, Fiorino F G, Saccetto L, Giarbini N, Carner M
ENT Department, University of Verona, Italy.
Audiology. 1999 Jul-Aug;38(4):225-34. doi: 10.3109/00206099909073026.
The preliminary results of insertion of a cochlear implant via the middle fossa in nine patients with profound bilateral hearing loss are described. Aetiologies included a bilateral radical mastoidectomy cavity, adhesive otitis media, autoimmune inner ear disease, previous cranial trauma, genetic pre-lingual deafness, and otosclerosis. A classic middle fossa approach was adopted. A small cochleostomy measuring 1.5 mm in diameter was performed on the most superficial part of the basal turn. A Nucleus 24M cochlear implant system (Cochlear Corporation) was inserted in four patients, a Lauraflex implant (Philips Hearing Implants) was used in three patients and a Combi 40+ (Med-el) with a double electrode array in two. Single electrode arrays were inserted from the cochleostomy to the cochlear apex and occupied a portion of the basal turn, as well as the middle and apical turns. Double electrode arrays were inserted, one towards the apex and one into the basal turn of the cochlea towards the round window. The receiver stimulator was positioned in a bone well previously drilled in the temporal squama and the electrode carrier was inserted in the fenestrated cochlea. The activity of the inserted electrodes was tested by means of telemetry and intraoperative recording of electrically evoked auditory brainstem responses (EABR). Speech recognition tests, performed over a period of time ranging from one to six months after cochlear implant activation, yielded better results in these patients compared with those obtained in postlingually deaf patients operated on via the traditional transmastoid route. Cochlear implant insertion via the middle fossa approach is a technique which is suitable for the implantation of patients with bilateral radical mastoidectomy cavities, chronic middle ear disease, middle ear malformations, or with partial obliteration of the cochlea in the basal turn. However, the main advantage of inserting the implant through the middle fossa cochleostomy consists in the possibility of stimulating, with the single array, areas of the cochlea, i.e. part of the basal, middle and apical turns, where a greater survival rate of spiral ganglion cells is known to occur. In addition, with the double array total occupation of the cochlea is possible, providing the possibility of replicating the tonotopic organization of the cochlea. This new approach has led to major improvements in speech recognition in all patients compared with patients operated on via the transmastoid approach and, given the present state of the art, may be the elective approach for optimal implantation outcomes.
本文描述了9例双侧极重度听力损失患者经中颅窝植入人工耳蜗的初步结果。病因包括双侧根治性乳突切除腔、粘连性中耳炎、自身免疫性内耳疾病、既往颅脑外伤、遗传性语前聋和耳硬化症。采用经典的中颅窝入路。在蜗底最浅部进行直径1.5mm的小耳蜗开窗术。4例患者植入Nucleus 24M人工耳蜗系统(科利耳公司),3例患者使用劳拉弗莱克斯植入体(飞利浦听力植入公司),2例患者使用带有双电极阵列的Combi 40+(美迪乐公司)。单电极阵列从耳蜗开窗处插入至蜗顶,占据蜗底部分以及蜗中和蜗顶转。双电极阵列插入,一个朝向蜗顶,一个插入耳蜗蜗底转向圆窗。接收器刺激器置于颞鳞部预先钻好的骨槽内,电极载体插入开窗的耳蜗。通过遥测和术中记录电诱发听觉脑干反应(EABR)测试插入电极的活性。在人工耳蜗激活后1至6个月的时间段内进行的言语识别测试显示,与经传统经乳突途径手术的语后聋患者相比,这些患者取得了更好的结果。经中颅窝入路植入人工耳蜗是一种适用于双侧根治性乳突切除腔、慢性中耳疾病、中耳畸形或蜗底部分耳蜗闭塞患者的植入技术。然而,通过中颅窝耳蜗开窗植入人工耳蜗的主要优势在于,使用单电极阵列有可能刺激耳蜗的区域,即蜗底、蜗中和蜗顶转的部分,已知这些区域螺旋神经节细胞的存活率更高。此外,使用双电极阵列可以完全占据耳蜗,从而有可能复制耳蜗的音调组织。与经乳突入路手术患者相比,这种新方法在所有患者的言语识别方面带来了重大改善,并且就目前的技术水平而言,可能是实现最佳植入效果的首选方法。